Regulatory differences exist due to varying healthcare infrastructures, economic conditions, political landscapes, and cultural beliefs. Each country may have its own set of challenges and priorities, leading to different approaches to cancer care. For example, a low-income country may focus more on affordable and accessible treatments, while a high-income country might invest heavily in cutting-edge research and advanced therapies.